DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Tranmep is a drug marketed by Solvay and is included in two NDAs.
The generic ingredient in TRANMEP is meprobamate. There are twenty-two drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the meprobamate profile page.
A generic version of TRANMEP was approved as meprobamate by INVAGEN PHARMS on February 27th, 2008.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Solvay||TRANMEP||meprobamate||TABLET;ORAL||084369-001||Approved Prior to Jan 1, 1982||DISCN||No||No||⤷ Try it Free||⤷ Try it Free||⤷ Try it Free|
|Solvay||TRANMEP||meprobamate||TABLET;ORAL||016249-001||Approved Prior to Jan 1, 1982||DISCN||No||No||⤷ Try it Free||⤷ Try it Free||⤷ Try it Free|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|